focus -WSS

focus

author：comprehensive 2025-09-30 08:45:48 - browse：199

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： STAT Summit: GSK CEO on pharma giant's new direction

WSS

Impact of Dobbs ruling felt at reproductive medicine meeting

NIH confirmation hearing shows politicization of research

NFL doctors' conflicts of interest could endanger players, report says

STAT Summit: Michael J. Fox on progress in Parkinson's research

'Brian's Song' at 50 still offers lessons about cancer for today

Trump used to be more articulate. What could explain the change?

entertainment

focus

knowledge

Tori Bowie and the unacceptable rates of Black maternal death

Senate committee scrutinizes Medicare Advantage brokers

Heart attack and stroke risk calculators need revising

Slovenia has suffered its worst

What does generative AI mean for health care? We asked experts

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Continuity nursing helped my family in our darkest PICU moments

Tuberculosis patients need more than just free medication

Moonlake's readout produced a cash windfall. Risks remain

NFL doctors' conflicts of interest could endanger players, report says

Wikipedia

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Tuberculosis patients need more than just free medication

Feed a cold, starve a fever? Here’s what science says

Paxlovid rebound happens. Why and to whom are still a mystery

Solve the antibiotic resistance crisis with preventive drugs

Sage considers ways to reduce costs following FDA rejection

leisure time

focus

leisure time

hotspot